Mitigating stress-related cell loss in islet replacement therapy for type 1 diabetes (T1D)

This funding opportunity will support projects aimed at reducing the fraction of islet cells lost in the post-transplant period with a focus on improving stress resilience of engrafted cells to enable more durable therapies.

Funding: $750,000 total 

Duration: 3 years

Research Authority due date: 12.11.26

LOI (required) due date: 19.11.27

Full proposal due date: 28.1.26